JP2007523111A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523111A5
JP2007523111A5 JP2006553508A JP2006553508A JP2007523111A5 JP 2007523111 A5 JP2007523111 A5 JP 2007523111A5 JP 2006553508 A JP2006553508 A JP 2006553508A JP 2006553508 A JP2006553508 A JP 2006553508A JP 2007523111 A5 JP2007523111 A5 JP 2007523111A5
Authority
JP
Japan
Prior art keywords
factor xiii
preparation
preparation according
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006553508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007523111A (ja
Filing date
Publication date
Priority claimed from EP04003950A external-priority patent/EP1566183A1/en
Application filed filed Critical
Publication of JP2007523111A publication Critical patent/JP2007523111A/ja
Publication of JP2007523111A5 publication Critical patent/JP2007523111A5/ja
Pending legal-status Critical Current

Links

JP2006553508A 2004-02-20 2005-02-15 虚血性組織の潅流を刺激するためのxiii因子の使用 Pending JP2007523111A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003950A EP1566183A1 (en) 2004-02-20 2004-02-20 Use of factor XIII for stimulating the perfusion of ischemic tissue
PCT/EP2005/001495 WO2005079839A1 (en) 2004-02-20 2005-02-15 Use of factor xiii for stimulating the perfusion of ischemic tissue

Publications (2)

Publication Number Publication Date
JP2007523111A JP2007523111A (ja) 2007-08-16
JP2007523111A5 true JP2007523111A5 (https=) 2008-04-03

Family

ID=34707356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006553508A Pending JP2007523111A (ja) 2004-02-20 2005-02-15 虚血性組織の潅流を刺激するためのxiii因子の使用

Country Status (11)

Country Link
US (1) US20070167361A1 (https=)
EP (2) EP1566183A1 (https=)
JP (1) JP2007523111A (https=)
KR (1) KR20060123567A (https=)
AT (1) ATE429244T1 (https=)
AU (1) AU2005215114B2 (https=)
CA (1) CA2556805C (https=)
DE (1) DE602005014085D1 (https=)
DK (1) DK1718328T3 (https=)
ES (1) ES2325996T3 (https=)
WO (1) WO2005079839A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20130532A1 (it) * 2013-06-27 2014-12-28 Donato Gemmati Nuovo biomarcatore prognostico nell'infarto acuto del miocardio

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69431430T2 (de) * 1993-03-30 2003-05-22 Hoechst Japan Ltd., Tokio/Tokyo Faktor XIII zur Behandlung von Hautwunden
AU7483798A (en) * 1997-05-14 1998-12-08 Zymogenetics Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage
EP1572168B1 (en) * 2002-02-06 2010-05-26 Vicor Technologies, Inc. Anti-infarction molecules

Similar Documents

Publication Publication Date Title
RU2533217C3 (ru) Препарат, содержащий инсулин, никотинамид и аминокислоту
JP2021504423A5 (https=)
JP2012505014A5 (https=)
JP2009545310A5 (https=)
HRP20131120T1 (hr) Farmaceutski pripravak koji sadrži (1s)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1-tio-d-glucitol i metformin, te njegova uporaba za lijeäśenje dijabetesa
JP2006522823A5 (https=)
RU2015144182A (ru) Пиразоламидное соединение и его применения в медицине
CN102908355B (zh) 一种药物组合物及其用途
IL155524A (en) Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
RU2007118691A (ru) Применение 4-трифторметилфениламида (z)-2-циано-3-гидрокси-бут-2-еновой кислоты для лечения воспалительных заболеваний кишечника
JP2007523111A5 (https=)
MX2009013937A (es) Nuevo uso de compuestos quimicos farmacologicamente activos conocidos.
CL2013000021A1 (es) Forma cristalina delta de la sal de arginina de perindoprilo; procedimiento de preparacion; composiciones farmaceuticas que la contienen; y su uso par el tratamiento de las enfermedades cardiovasculares, tales como hipertension arterial, insuficiencia cardiaca o enfermedad coronaria estable.
RU2004136583A (ru) Применение валсартана или его метаболита для ингибирования агрегации тромбоцитов
Chello et al. Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning
Glancy et al. Myocardial infarction with ventricular septal rupture and cardiogenic shock
CN207236818U (zh) 微创小切口心脏直视手术无损伤主动脉阻闭钳
CN207286247U (zh) 一种具有隐藏吊水杆结构的心内科护理床
CN204744775U (zh) 一种心血管病人设计的专用护理装置
CN100582120C (zh) 21-亚基地高辛衍生物及其制备方法
Migotto et al. Effects of vasopressin on hemodynamics in cardiogenic shock
CN102440812A (zh) 深部打结钳
Danica et al. Renal thromboembolism in tako-tsubo cardiomyopathy in spite of anticoagulation
Yuriivna et al. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block-a case report
Wang et al. Structure-guided design of Cryptococcus neoformans protein farnesyltransferase inhibitors with antifungal activity